Chevron's Earnings Deteriorate but Outlook Improved
Chevron’s dividend remains safe, in our view, with relatively low leverage levels, an improved cost structure, and the likelihood of improving cash flow.
Chevron (CVX) reported a loss of $665 million during the fourth quarter compared with a loss of $6.6 billion the year before, which included $10.4 billion in impairments. Earnings worsened from a loss of $207 million in the third quarter as downstream and corporate segment losses increased and offset higher profits from the upstream segment.
Full-year operating cash flow of $10.6 billion and asset sale proceeds of $3.0 billion were insufficient to cover $9.9 billion in cash capital expenditures and loans and $9.7 billion in dividends. The shortfall along with assumption of Noble debt resulted in the net debt/capital ratio rising to 23% from 13% at the end of 2019. This is still within management's targeted range and the lowest of the peer group.
Our fair value estimate and narrow moat rating are unchanged. Although earnings deteriorated during the fourth quarter, we expect an improved macroeconomic environment in 2021, which should lift commodity prices and margins as vaccines are distributed and the pandemic recedes. Meanwhile, Chevron’s dividend remains safe, in our view, with relatively low leverage levels, an improved cost structure, and the likelihood of improving cash flow. During 2020, Chevron achieved more than $1 billion in operating expense reductions and reduced capital spending by 35% compared with 2019. Both should hold in 2021, with capital spending remaining flat at about $14 billion and between $14 billion and $16 billion through 2024. On the basis of these plans, we project Chevron’s break-even level to be below $50/barrel in 2021, which is below current forward prices. As such, the 20% discount to our fair value estimate and 6% yield indicate value, in our view. Further updates on long-term plans and carbon-reduction strategies should come in early March at the company’s annual analyst day.
|Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.|
Allen Good does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.